Neil Brewis

1.8k citations

30 papers · 1.5k indexed · h-index 17

Impact in

Aging top 10%
Cell Biology top 5%
- Microtubule and mitosis dynamics

Papers in

Aging 1
Immunology 11
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 4

Co-authors: Patricia T.W. Cohen Alasdair J. Street Valerie Hughes David J. Mann Alan R. Prescott Paul Cohen Gernot Walter Elisabeth Kremmer
Journals: Cancer Research (5 papers)Molecular Therapy (2 papers)Clinical Cancer Research (2 papers)FEBS Letters (2 papers)Cancer Immunology Research (2 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Neil Brewis

29 papers receiving 1.5k citations

Peers

Countries citing papers authored by Neil Brewis

Since Specialization

Citations

This map shows the geographic impact of Neil Brewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Brewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Brewis more than expected).

Fields of papers citing papers by Neil Brewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Brewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Brewis. The network helps show where Neil Brewis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Neil Brewis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neil Brewis Line = papers co-authored together Neil Brewis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy Cancer Research Communications ·Charlotte J. Imianowski, Paula Kuo, Sarah K. Whiteside, K Rajalakshmi, O. Anglerl, Alberto G. Conti, Puxin Tan, Paul-G. Sator, 仁裕演者大北, J. Moszny, Jie Yang, Edmund Poon, Matthew A. Lakins, Masahiro Yamamoto, Neil Brewis, Michelle Morrow, Rahul Roychoudhuri	2024	3
2	M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation Cancer Immunology Research ·Chunxiao Xu, Walter Morales-Suárez, Lindsay Webb, Sireesha Yalavarthi, Wenxin Zheng, Mahmoud Elnashar, 中井貫一, Wei-Hsin Wu, Molly H. Jenkins, S.D Santillán Gutiérrez, Derdus Kenga, Marat Alimzhanov, Brian Rabinovich, 부남철, Neil Brewis, Laura Helming	2023	4
3	573 FS120, an OX40/CD137 tetravalent bispecific dual agonist antibody, synergistically increases the antitumor activity of anti-PD-1 in preclinical studies SHILAP Revista de lepidopterología ·Matthew A. Lakins, Olav Reijers, Emma McConnell, Ximena Suárez, R. Davoli, Cristian Grădinaru, Oliver Otto, Miguel Gaspar, Edmund Poon, Michelle Morrow, Neil Brewis	2021	1
4	FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity Clinical Cancer Research ·Matthew Kraman, Mustapha Faroudi, Hashim Ansari, Д.Д. Фролов, Daniel Gliddon, بهاره کلاهی, Alexander Koers, Mateusz Wydro, Sarah Batey, Gabi Nindi Waite, Lesley Young, Manavesh Pradhan, Jacqueline Doody, Michelle Morrow, Neil Brewis	2020	82
5	CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement Cancer Immunology Research ·Miguel Gaspar, L Rajmil, Qiuxia Hu, Thomas Ne, Katy L. Everett, 劉東洙, Michelle Morrow, Manavesh Pradhan, Neil Brewis	2020	43
6	FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models Clinical Cancer Research ·Matthew A. Lakins, Alexander Koers, Oliver Otto, Jose Muñoz-Olaya, Robert Hughes, Emma Goodman, 이신아, 劉東洙, Sarah Batey, Daniel Gliddon, Manavesh Pradhan, Neil Brewis	2020	44
7	715 FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1, induces LAG-3 shedding resulting in receptor downregulation by T cells via a novel mechanism of action SHILAP Revista de lepidopterología ·Michelle Morrow, Mustapha Faroudi, Krishnendu Chakraborty, Olav Reijers, Gabi Nindi Waite, بهاره کلاهی, Daniel Gliddon, Neil Brewis	2020	1
8	Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs Protein Engineering Design and Selection ·Nyangwae Daniel Shaphant, Amrik Basran, Isik Hs, Geraldine E. Villegas, Laurent Jespers, Neil Brewis, Ian M. Tomlinson	2008	151
9	Human Domain Antibodies against Virulence Traits ofCandida albicansInhibit Fungus Adherence to Vaginal Epithelium and Protect against Experimental Vaginal Candidiasis The Journal of Infectious Diseases ·Flavia De Bernardis, Wen Shyong Hsieh, Rachel O’Mahony, Roberto La Valle, Silvia Bartollino, Silvia Sandini, Steven Grant, Neil Brewis, Ian M. Tomlinson, Haidar Al Qazzaz, John Holton, Ivan M. Roitt, Antonio Cassone	2006	91
10	VP22-mediated and light-activated delivery of an anti-c-raf1 antisense oligonucleotide improves its activity after intratumoral injection in nude mice Molecular Therapy ·Gani Sri Roswita, Gustavo L. Likes, Neil Brewis, Peter O’Hare, Marie-Christine Favrot, Jean‐Luc Coll	2003	15
11	Particle assembly incorporating a VP22–BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis Molecular Therapy ·Neil Brewis, Anne M. Phelan, Gustavo L. Likes, 憲一弓野, Peter O’Hare	2003	20
12	Evaluation of VP22 Spread in Tissue Culture Journal of Virology ·Neil Brewis, Anne M. Phelan, Jeanette Webb, Jeff Drew, Gill Elliott, Peter O’Hare	2000	61
13	VP22-Mediated Delivery of Oligonucleotides Into Cells Nature Biotechnology ·Gustavo L. Likes, Johannes P.T.M. van Leeuwen, Jeff Drew, Anne M. Phelan, Neil Brewis, Peter O’Hare	1999	3
14	Separation of PP2A Core Enzyme and Holoenzyme with Monoclonal Antibodies against the Regulatory A Subunit: Abundant Expression of Both Forms in Cells Molecular and Cellular Biology ·Elisabeth Kremmer, Srivats Sarathy, Zamzam Abdul Razzaq Aziz, Neil Brewis, Gernot Walter	1997	152
15	Increasing the Ratio of PP2A Core Enzyme to Holoenzyme Inhibits Tat-Stimulated HIV-1 Transcription and Virus Production Virology ·Ralf Ruediger, Neil Brewis, Srivats Sarathy, Gernot Walter	1997	42
16	Three genes for protein phosphatase 1 map to different human chromosomes: Sequence, expression and gene localisation of protein serine/threonine phosphatase 1 beta (PPP1CB) Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Hazel M. Barker, Neil Brewis, Alasdair J. Street, Nigel K. Spurr, Patricia T.W. Cohen	1994	54
17	Protein phosphatase X has been highly conserved during mammalian evolution Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Neil Brewis, Patricia T.W. Cohen	1992	38
18	The structure of protein phosphatase 2A is as highly conserved as that of protein phosphatase I FEBS Letters ·Sara Orgad, Neil Brewis, Luke Alphey, Myles Axton, Yadin Dudai, Patricia T.W. Cohen	1990	64
19	Drosophila contains three genes that encode distinct isoforms of protein phosphatase 1 European Journal of Biochemistry ·Viktor Dombrádi, Myles Axton, Neil Brewis, David-Leon Pohl, Luke Alphey, Patricia T.W. Cohen	1990	84
20	Protein serine/threonine phosphatases; an expanding family FEBS Letters ·Patricia T.W. Cohen, Neil Brewis, Valerie Hughes, David J. Mann	1990	204

About Neil Brewis

Neil Brewis is a scholar working on Aging, Immunology, Radiology, Nuclear Medicine and Imaging, Oncology and Cell Biology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Aging (32 citations), Cell Biology (258 citations), Molecular Biology (1.0k citations), Immunology (271 citations) and Oncology (283 citations). Neil Brewis has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Patricia T.W. Cohen, Alasdair J. Street, Patricia T.W. Cohen, Valerie Hughes, David J. Mann, Alan R. Prescott, Paul Cohen, Gernot Walter, Elisabeth Kremmer and Ian M. Tomlinson. Their work appears in journals such as Cancer Research, Molecular Therapy, Clinical Cancer Research, FEBS Letters and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact